Mica - OmicsDI

Show results for

Unknown (938)
Genomics (51)
Transcriptomics (50)
Proteomics (18)
Metabolomics (2)
Genomic (1)
Models (1)

Organisms

Homo sapiens (36)
Andropogon gerardi (10)
Bacteria (10)
Canis lupus familiaris (10)
Clostridium perfringens (10)
Cnidaria (10)
Cricetulus griseus (10)
Eukaryota (10)
Fasciola (10)
Hepatitis B virus (10)
Human betaherpesvirus 5 (10)
Madurella mycetomatis (10)
Mesocricetus auratus (10)
Miscanthus x giganteus (10)
Mus musculus (10)
Mycobacterium tuberculosis (10)
Orthoflavivirus (10)
Panicum virgatum (10)
Platyhelminthes (10)
Pseudomonas aeruginosa AES-1R (10)
Rattus norvegicus (10)
Rattus rattus (10)
Mus musculus (6)
Escherichia coli (4)
Vitis vinifera (3)
Staphylococcus aureus (2)
Sinorhizobium meliloti (2)
Staphylococcus epidermidis (1)
Escherichia coli str. K-12 substr. MG1655 (1)
Rattus norvegicus (1)

Organisms

Homo sapiens (16)
Mus musculus (6)
Brevibacterium aurantiacum (4)
Escherichia coli (4)
Staphylococcus xylosus (2)
Kluyveromyces lactis (1)
Bacillus cereus ATCC 14579 (1)

Repository

ENA (50)
biostudies-arrayexpress (37)
geo (17)
pride (10)
MassIVE (4)
MetaboLights (2)
dbGaP (1)
EGA (1)
PMR (1)

Tissue

Biofilm (1)
Blood cell (1)
Cell culture (1)
Epithelial cell (1)
Hyphal cell (1)
Yeast (1)

Disease

Malignant neoplasm of ovary (2)
Normal (1)
COVID-19 (1)

Technology Type

Mass Spectrometry (10)
Bottom-up proteomics (7)
Shotgun proteomics (3)
Mass spectrometry (2)
Data-independent acquisition (1)

Instrument Platform

Illumina HiSeq 2500 (2)
Liquid Chromatography MS - positive - reverse phase (2)
Liquid Chromatography MS - negative - reverse phase (2)
LTQ (2)
Illumina Genome Analyzer IIx (1)
NextSeq 500 (1)
LTQ Orbitrap Velos (1)
Orbitrap Exploris 480 (1)
Q Exactive (1)
Thermo Fisher Q Exactive Plus Hybrid Quadrupole-Orbitrap (1)
4800 MALDI TOF TOF (1)

Publication Date

2014 (10)
2010 (8)
2016 (7)
2022 (6)
2018 (6)
2020 (5)
2025 (5)
2015 (4)
2013 (3)
2012 (3)
2023 (3)
2024 (2)
2011 (1)
2007 (1)
2026 (1)
2009 (1)
2008 (1)
2019 (1)
2017 (1)
2021 (1)

CHEBI ID

CHEBI:185590 (1)
CHEBI:185033 (1)
CHEBI:185082 (1)
CHEBI:184433 (1)
CHEBI:185588 (1)
CHEBI:185586 (1)
CHEBI:185161 (1)
CHEBI:185584 (1)
CHEBI:184906 (1)
CHEBI:185183 (1)
CHEBI:185582 (1)
CHEBI:185580 (1)
CHEBI:184474 (1)
CHEBI:184829 (1)
CHEBI:185175 (1)
CHEBI:184782 (1)
CHEBI:185578 (1)
CHEBI:184420 (1)
CHEBI:185576 (1)
CHEBI:184776 (1)
CHEBI:184405 (1)
CHEBI:185575 (1)
CHEBI:185573 (1)
CHEBI:185571 (1)
CHEBI:185568 (1)
CHEBI:185013 (1)
CHEBI:185567 (1)
CHEBI:168656 (1)
CHEBI:184791 (1)
CHEBI:169793 (1)

Metabolite Name

PS(DIME(11,5)/MONOME(13,5)) (1)
4,4,10-Trimethyl-1,11-bis(3-methylbut-2-en-1-yl)-10-(4-methylpent-3-en-1-yl)-9-(2-methylpropanoyl)-3-oxatricyclo[7.3.1.0²,⁷]trideca-2(7),5-diene-8,13-dione (1)
2-{[3,4-dihydroxy-5,6-bis({[(2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoyl]oxy})oxan-2-yl]methoxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl (2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate (1)
{2-[(7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoyloxy]-3-(tetracosanoyloxy)propoxy}[2-(methylamino)ethoxy]phosphinic acid (1)
TG(20:1(11Z)/22:2(13Z,16Z)/20:2(11Z,14Z)) (1)
1-(8-{[6-({[3,5-dihydroxy-6-(hydroxymethyl)-4-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-1-hydroxy-6-methoxy-3-methylnaphthalen-2-yl)ethan-1-one (1)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-({[3-(methylsulfanyl)propyl]thio(carbonoimidyl)}sulfanyl)ethyl}-C-hydroxycarbonimidoyl)butanoic acid (1)
(2E)-N-{2-[5,5'-dihydroxy-3'-(2-{[(2E)-1-hydroxy-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-ylidene]amino}ethyl)-1H,1'H-[4,4'-biindole]-3-yl]ethyl}-3-(4-hydroxyphenyl)prop-2-enimidic acid (1)
(2R,3R)-2-(3,4-Dihydroxyphenyl)-6-[(2R,3R,4S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3,4,5-trihydroxybenzoyloxy)-3,4-dihydro-2H-1-benzopyran-4-yl]-5,7-dihydroxy-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate (1)
2-(Hydroxymethyl)-6-[(3,4,5-trihydroxy-6-{[16-hydroxy-2,6,6,10,11-pentamethyl-14-(6-methyl-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hept-5-en-2-yl)tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-5-yl]oxy}oxan-2-yl)methoxy]oxane-3,4,5-triol (1)
6-(16'-{[3,4-dihydroxy-6-(hydroxymethyl)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-15'-oloxy)-3,4,5-trihydroxyoxane-2-carboxylic acid (1)
3-[({2-[(3-{[4-({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-1,2-dihydroxy-3,3-dimethylbutylidene]amino}-1-hydroxypropylidene)amino]ethyl}sulfanyl)carbonyl]-4-hydroxy-4-phenylbutanoic acid (1)
PC(O-22:1(13Z)/22:2(13Z,16Z)) (1)
4-({[({[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-2-hydroxy-N-[2-({2-[(11E)-icos-11-enoylsulfanyl]ethyl}-C-hydroxycarbonimidoyl)ethyl]-3,3-dimethylbutanimidic acid (1)
(1R,2R,3R,11S,12S,14R,26R)-5,6',7',12-tetrahydroxy-6-methoxy-7,21,30-trimethyl-27-oxo-3',4'-dihydro-2'H-17,19,28-trioxa-24-thia-13,30-diazaspiro[heptacyclo[12.9.6.1³,¹¹.0²,¹³.0⁴,⁹.0¹⁵,²³.0¹⁶,²⁰]triacontane-26,1'-isoquinoline]-4(9),5,7,15(23),16(20),21-hexaen-22-yl acetate (1)
Ps(14:1(9z)/20:5(5z,8z,11z,14z,17z)) (1)
2-[6'-(5,7-Dihydroxy-4-oxo-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4H-chromen-2-yl)-2',3',4,4',5,6-hexahydroxy-[1,1'-biphenyl]-2-yl]-5,7-dihydroxy-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate (1)
Heptacosane-6,8-dione (1)
3,4,5-trihydroxy-6-{[5-hydroxy-14-(1-hydroxy-6-methylhept-5-en-2-yl)-2,11,15-trimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-1(10)-en-8-yl]oxy}oxane-2-carboxylic acid (1)
2-[(7-{[4,5-dihydroxy-6-(hydroxymethyl)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl)oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl (2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate (1)
TG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (1)
2-[2-({7-[(3-carboxy-3-{2-[(6-carboxy-3,4,5-trihydroxyoxan-2-yl)oxy]-2-oxoethyl}propanoyl)oxy]-11,16,18-trihydroxy-19-[(1-hydroxyethylidene)amino]-5,9-dimethylicosan-6-yl}oxy)-2-oxoethyl]butanedioic acid (1)
(6-{4-[2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-8-yl]-3,5,7-trihydroxy-2-(3-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-8-yl}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl)oxidanesulfonic acid (1)
[6,7,8,11,12,13,23-heptahydroxy-3,16-dioxo-21-(3,4,5-trihydroxybenzoyloxy)-2,17,20-trioxatetracyclo[17.3.1.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,6,8,10,12,14-hexaen-22-yl]oxidanesulfonic acid (1)
N-Isobutyl-2E,4Z-octadecadienoyl amine (1)
PA(O-16:0/18:0) (1)
(4,5-dihydroxy-2-{[(1E)-3-hydroxy-3-methyl-1-[(sulfooxy)imino]pentyl]sulfanyl}-6-(hydroxymethyl)oxan-3-yl)oxidanesulfonic acid (1)
{[(2R,3R,5R)-3,4-dihydroxy-5-(2-hydroxy-4-imino-1,4-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy}({hydroxy[(2R)-3-[(14-methylpentadecanoyl)oxy]-2-[(9Z,11Z)-octadeca-9,11-dienoyloxy]propoxy]phosphoryl}oxy)phosphinic acid (1)
{4-[2-(3,5-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-8-yl]-5,7-dihydroxy-2-(3-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl}oxidanesulfonic acid (1)
(2S,15R)-14-(5-ethyl-6-methylheptan-2-yl)-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-7-ylium-5-olate (1)

First Public Date

2014 (14)
2022 (6)
2025 (5)
2023 (5)
2024 (4)
2020 (4)
2013 (4)
2018 (3)
2026 (2)
2019 (2)
2015 (1)

Classification

bacteria (5)

Modification

Not available (3)

Study type

Transcription profiling by array (21)
RNA-seq of coding RNA (5)
MicroRNA profiling by high throughput sequencing (2)
Proteomic profiling by array (2)
RNA-seq of non coding RNA (2)
Cell line - One-color microarray (1)
Transcription profiling by tiling array (1)
Genotyping by array (1)
Bisulfite-seq (1)
Comparative genomic hybridization by array (1)

Release Date

2025 (101)
2023 (98)
2022 (83)
2024 (75)
2021 (75)
2020 (70)
2016 (65)
2018 (63)
2017 (60)
2019 (58)
2015 (46)
2014 (39)
2013 (25)
2011 (22)
2010 (20)
2012 (17)
2009 (16)
2026 (9)
2008 (8)
2006 (6)
2007 (5)
2004 (3)
2002 (3)
2005 (2)
2003 (2)
2001 (1)
1999 (1)
1998 (1)
1997 (1)

Lab affiliation

Unidad de ProteÃ³mica UCM-PCM (4)
IBMC (2)
1. Department of Paediatrics, University Hospital of North Norway, Tromsø, Norway 2 Paediatric Research Group, Department of Clinical Medicine, Faculty of Health Sciences, UiT- The Arctic University of Norway, Tromsø, Norway. (1)
Cambridge Institute of Therapeutic Immunology and Infectious Disease, Cambridge, UK (1)
Departamento de Microbiología II, Universidad Complutense Madrid (1)
Laboratory of Post-Transcriptional Control of Gene Expression, Institute of Microbiology of the Czech Academy of Sciences, Czech Republic (1)

Previous page
1 / 107
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 107
Next page

Sort by:

Relevance

Page size

Global gene transcriptional profiles in RAW 264.7 cells following mica fine particle stimulation

We focused on how mica fine particle influences macrophage activities. We analyzed altered transcription in RAW 264.7 cells at 0, 12, and 48 h following the stimulation with 100 M-BM-5g/mL of mica fine particles.

ORGANISM(S): Mus musculus

2014-12-04 | E-GEOD-63827 | biostudies-arrayexpress

RNA-seq data of Escheirchia coli K12 MG1655 of overexpression of GcvB, MicA, ArcZ, RyhB or CyaR sRNAs

To study the regulatory outcome of Hfq-mediated sRNA-target interactions, we measured the change in gene expression following overexpression of each of five well-established sRNAs: GcvB, MicA, ArcZ, RyhB and CyaR. For each of the studied sRNAs we applied RNA-seq to two E. coli K-12 MG1655 strains: (...

ORGANISM(S): Escherichia coli str. K-12 substr. MG1655

2020-03-03 | E-MTAB-8229 | biostudies-arrayexpress

Technical controls MiCA

PRJEB30293 | ENA

Compartmental Localization and Clinical Relevance of MICA Antibodies after Renal Transplantation

Background: Studies recently support that non-HLA antigens could be additional targets of injury in organ transplant recipients, and MICA was associated with an increased risk of graft loss. Methods: A ProtoArray platform was used to study 37 serum samples from 22 unique patients (15 renal recipient...

ORGANISM(S): Homo sapiens

2009-01-16 | GSE14329 | GEO

Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity

PRJNA431361 | ENA

Compartmental Localization and Clinical Relevance of MICA Antibodies after Renal Transplantation

ORGANISM(S): Homo sapiens

2010-05-06 | E-GEOD-14329 | biostudies-arrayexpress

Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity

MICA and MICB (MICA/B) are expressed by many human cancers due to cellular stress and tag cells for elimination by cytotoxic lymphocytes through NKG2D receptor activation. However, tumors evade this immune recognition pathway through proteolytic shedding of MICA/B proteins. We rationally designed an...

ORGANISM(S): Homo sapiens Mus musculus

2018-02-01 | GSE109542 | GEO

Global analysis of the Hfq-mediated RNA interactome discovers a MicA homolog of Bordetella pertussis

Bordetella pertussis is a Gram-negative, strictly human re-emerging respiratory pathogen and the causative agent of whooping cough. The requirement of the RNA chaperone Hfq for the virulence of B. pertussis suggests that Hfq-dependent small regulatory RNAs (sRNAs) are involved in the virulence of th...

ORGANISM(S): Bordetella pertussis (strain Tohama I / ATCC BAA-589 / NCTC 13251)

2025-07-14 | PXD063711 | Pride

Global gene transcriptional profiles in RAW 264.7 cells following mica fine particle stimulation

We focused on how mica fine particle influences macrophage activities.

ORGANISM(S): Mus musculus

2014-12-04 | GSE63827 | GEO

MICA and MICB genotpying

PRJEB100726 | ENA

Previous page
1 / 107
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 107
Next page

Sort by:

Relevance

Page size

1061 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Classification

Modification

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets